Schvartsman, G., Provencio, M., Peters, S., Zhang, Z., Naicker, K., Zhao, N., Lin, X., Taylor, M. A., Wang, W., Chen, Q., Yu, B., Jiang, J., Hu, J., Wang, C. (2026). RATIONALE-315: Post hoc analysis of event-free survival by surgically relevant subgroups treated with perioperative tislelizumab and neoadjuvant chemotherapy vs neoadjuvant chemotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8059